$821 Million is the total value of ARCH Venture Management, LLC's 10 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | KARUNA THERAPEUTICS, INC. | $368,507,000 | -0.2% | 2,912,872 | 0.0% | 44.90% | -14.9% | |
| EQRX, INC. | $170,413,000 | +13.6% | 36,335,375 | 0.0% | 20.77% | -3.2% | ||
| DNLI | New | DENALI THERAPEUTICS, INC. | $152,116,000 | – | 5,168,749 | +100.0% | 18.54% | – |
| ERASCA, INC. | $61,579,000 | -35.2% | 11,055,554 | 0.0% | 7.50% | -44.8% | ||
| VERV | VERVE THERAPEUTICS, INC. | $38,335,000 | -33.0% | 2,508,809 | 0.0% | 4.67% | -42.9% | |
| OMIC | SINGULAR GENOMICS SYSTEMS, INC. | $14,512,000 | -39.5% | 3,798,926 | 0.0% | 1.77% | -48.4% | |
| REVH | New | REVOLUTION HEALTHCARE ACQUISITION CORP. | $13,260,000 | – | 1,357,237 | +100.0% | 1.62% | – |
| MTCR | METACRINE, INC. | $1,470,000 | -18.0% | 2,940,503 | 0.0% | 0.18% | -30.1% | |
| RUBY | RUBIUS THERAPEUTICS, INC. | $298,000 | -84.5% | 349,908 | 0.0% | 0.04% | -87.0% | |
| ZY | ZYMERGEN INC. | $147,000 | -57.4% | 119,205 | 0.0% | 0.02% | -63.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RUBIUS THERAPEUTICS, INC. | 12 | Q3 2022 | 65.5% |
| EQRX, INC. | 8 | Q3 2023 | 52.4% |
| ERASCA, INC. | 8 | Q3 2023 | 18.8% |
| VERVE THERAPEUTICS, INC. | 8 | Q3 2023 | 23.3% |
| CHIASMA INC | 8 | Q3 2020 | 25.7% |
| SINGULAR GENOMICS SYSTEMS, INC. | 8 | Q3 2023 | 4.6% |
| KURA ONCOLOGY INC | 7 | Q2 2020 | 27.6% |
| KARUNA THERAPEUTICS, INC. | 6 | Q1 2023 | 52.8% |
| DENALI THERAPEUTICS, INC. | 6 | Q3 2023 | 28.6% |
| SYROS PHARMACEUTICALS INC | 5 | Q3 2020 | 43.8% |
View ARCH Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-27 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View ARCH Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.